Reference
Hervas-Garcia JV, et al. Seroprevalence of SARS-cOV-2 in multiple sclerosis patients under immunomodulatory treatment in lleida (study emCOVID-19). Multiple Sclerosis Journal 26 (Suppl.): 59 abstr. LB1163, No. 3, Dec 2020. Available from: URL: http://doi.org/10.1177/1352458520974938
Rights and permissions
About this article
Cite this article
Multiple drugs. Reactions Weekly 1843, 247 (2021). https://doi.org/10.1007/s40278-021-91349-z
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40278-021-91349-z